Interaction of the pBR 322-coded RTEM beta-lactamase with substrates. Evidence for specific conformational

The Biochemical Journal
|February 1, 1982
PubMed

Insights

Class A penicillins speed up RTEM-1 beta-lactamase inactivation by Pronase. Other penicillins and cephalosporins offer protection, while cefoxitin causes a prolonged, complex inactivation response with trypsin and Pronase.

Area of Science:

  • Biochemistry
  • Enzymology
  • Microbiology

Background:

  • RTEM-1 beta-lactamase is a key enzyme conferring bacterial resistance to beta-lactam antibiotics.
  • Understanding its inactivation mechanisms is crucial for developing strategies to overcome antibiotic resistance.

Purpose of the Study:

  • To investigate the effects of different classes of penicillins and cephalosporins on the inactivation rate of RTEM-1 beta-lactamase by Pronase.
  • To characterize the interaction of cefoxitin with RTEM-1 beta-lactamase and its impact on enzyme inactivation.

Main Methods:

  • Enzyme kinetics assays were performed to measure the inactivation rates of RTEM-1 beta-lactamase.
  • The enzyme was pre-incubated with various beta-lactam antibiotics (class A penicillins, class S penicillin, cephalosporins, cefoxitin) before exposure to Pronase or trypsin.

Main Results:

  • Class A penicillins significantly accelerated the Pronase-mediated inactivation of RTEM-1 beta-lactamase.
  • Other substrates, including class S penicillin and cephalosporins, protected the enzyme from inactivation.
  • Cefoxitin induced a unique, hysteretic inactivation response, rendering the enzyme susceptible to both Pronase and trypsin.

Conclusions:

  • The inactivation of RTEM-1 beta-lactamase is modulated by different beta-lactam substrates, with class A penicillins acting as accelerators and others as protectants.
  • Cefoxitin exhibits a distinct mechanism of interaction, leading to a more profound and prolonged enzyme inactivation.
  • These findings provide insights into the complex interplay between beta-lactam antibiotics and beta-lactamase enzymes, relevant to antibiotic resistance research.

Related Concept Videos

Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...